Pricing
Pay for the monitoring. The evidence map is free.
Nebula is free while it is in beta. PharmaTerminal has a free tier and two paid tiers, billed monthly in US dollars.
PharmaTerminal
Plans are set and billed inside PharmaTerminal. Upgrades go through its own Stripe checkout — this site never handles a payment or a card.
Explorer
5 AI analyses / month
- Live pharma market data
- Breaking FDA/EMA news feed
- Drug pipeline tracker
- PDUFA calendar
- R&D prediction markets
- 5 AI analyses / month
- Community support
Professional
Most popular200 AI compound analyses / month
- Everything in Explorer
- 200 AI compound analyses / month
- Full publication database access
- Advanced market monitoring
- Clinical trial deep-dives
- PDF report export
- Priority email support
Enterprise
Best valueUnlimited AI analyses
- Everything in Professional
- Unlimited AI analyses
- Custom dashboards
- API access
- Team seats (up to 25)
- GDPR data processing agreement
- Dedicated account manager
- SLA 99.9% uptime guarantee
Nebula
Beta
- Full interactive citation map
- Paper metadata, abstracts and DOI links
- Corpus and edge-list export (JSON / ZIP)
- No account needed to browse
- No advertising, no third-party tracking, no analytics
Why it is free
Nebula is a beta: it currently publishes one curated corpus (mesenchymal stem cell secretome) rather than arbitrary queries, and it is honest in its own interface that the citation data behind the edges is partially sparse. Charging for a beta would mean charging for something still being proven.
Building evidence maps for your own technologies requires signing in. If you want a map built for a specific asset, that is a service rather than a subscription — see Services.